Case Study: Ofatumumab-Induced Remission in Refractory Panuveitis Accompanied by Multiple Sclerosis - Top-Institutions - MDSpire

Case Study: Ofatumumab-Induced Remission in Refractory Panuveitis Accompanied by Multiple Sclerosis

  • By

  • Agni M. Konitsioti

  • Jeany Q. Lammert

  • Sabine Vay

  • Gereon R. Fink

  • Michael Schroeter

  • Clemens Warnke

  • April 29, 2026

  • 0 min

Share

Top Institutions in Ophthalmology

Brief introduction explaining scope and methodology.

  • #1

    National Eye Institute (NEI), National Institutes of Health
    National Eye Institute (NEI), National Institutes of Health

    Bethesda, MD

    Key Differentiators

    • Ophthalmology
    • Immunology
    • Neuroimmunology

  • #2

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Ophthalmology
    • Neurology
    • Immunology

  • #3

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Ophthalmology
    • Neurology
    • Immunology

  • #4

    Massachusetts General Hospital (MGH), Harvard Medical School
    Massachusetts General Hospital (MGH), Harvard Medical School

    Boston, MA

    Key Differentiators

    • Ophthalmology
    • Neurology
    • Immunology

Original Source(s)

Case Study: Ofatumumab-Induced Remission in Refractory Panuveitis Accompanied by Multiple Sclerosis

  • by Agni M. Konitsioti, Jeany Q. Lammert, Sabine Vay, Gereon R. Fink, Michael Schroeter, Clemens Warnke

  • April 29, 2026

Related Content

Innovative One-Handed Syringe Handle Design for Anterior Chamber Paracentesis

Regulatory T cell dysfunction and exhaustion in uveitis: immunometabolic mechanisms, microenvironmental drivers, and emerging therapeutic strategies

Bile acid metabolomics reveals distinct immunometabolic niches and enables accurate diagnosis of AQP4-IgG–seronegative NMOSD